The consolidated opinion of the Committees for Risk Assessment and Socio-economic Analysis for the use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated by Janssen Vaccines & Prevention BV and Janssen Biologics B.V. is available on ECHA’s Website.
Despite the current COVID-19 pandemic situation and the internal reorganisation of our activities, the REACH&CLP Luxembourg Helpdesk remains available to answer all your questions regarding these regulations.